Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture
Open accessThe DOI matches its Crossref record.
Abstract
Background: It is well established that the wheat protein gliadin triggers inflammation in coeliac patients. However, the potential toxicity of avenin, the equivalent protein in oats, is debated. Aim: To investigate the immunogenicity of avenin using the cytokines interferon γ (IFN-γ) and interleukin (IL)-2 as markers of immunological activity. Methods: Duodenal biopsies from coeliac patients were cultured with 5 mg/ml of peptic tryptic (PT) gliadin (n=9) or 5 mg/ml of PT avenin (n=8) for four hours. Biopsies cultured with RPMI 1640 alone served as controls. Non-coeliac biopsies were also cultured with PT gliadin (n=8) and PT avenin (n=8). Total RNA was extracted from the tissue after culture. Cytokine mRNA was quantified by TaqMan polymerase chain reaction. Secreted cytokine protein was measured in the culture supernatant by enzyme linked immunosorbent assay. Results: After culture with PT gliadin, an increase in IFN-γ mRNA was observed in all nine patients with coeliac disease. Increased IFN-γ protein was also found in four of these patients. Smaller increases in IL-2 mRNA were detected in six subjects with increased IL-2 protein found in two patients. In contrast with PT gliadin, there was no significant IFN-γ or IL-2 response when coeliac biopsies were cultured with PT avenin. Similarly, biopsies from normal controls did not respond to PT gliadin or PT avenin stimulation. Conclusions: The findings of this study suggest that the immunogenic sequences in gliadin are not present in avenin. Moreover, they are in keeping with in vivo studies which report that oats are safe for consumption by coeliac patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Butt, M. S., Tahir-Nadeem, M., Khan, M. K. I., Shabir, R., & Butt, M. S. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0698-7 · Cited by 559
“However, the potential toxicity of avenin, the corresponding protein in oats has been evaluated and the results showed that the immunogenic sequences present in gliadin are missing in avenin [ 68 ].”
ResultThe Molecular Basis for Oat Intolerance in Patients with Celiac Disease
Arentz-Hansen, H., Fleckenstein, B., Molberg, Ø., Scott, H., Koning, F., Jung, G., Roepstorff, P., Lundin, K. E. A., & Sollid, L. M. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010001 · Cited by 280
Gluten-free Sourdough Wheat Baked Goods Appear Safe for Young Celiac Patients: A Pilot Study
Di Cagno, R., Barbato, M., Di Camillo, C., Rizzello, C. G., De Angelis, M., Giuliani, G., De Vincenzi, M., Gobbetti, M., & Cucchiara, S. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181f22ba4 · Cited by 97
Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder
Dunne, M. R., Byrne, G., Chirdo, F. G., & Feighery, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01374 · Cited by 85
Self-citationSafety of Oats in Children with Celiac Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
Lionetti, E., Gatti, S., Galeazzi, T., Caporelli, N., Francavilla, R., Cucchiara, S., Roggero, P., Malamisura, B., Iacono, G., Tomarchio, S., et al. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.10.062 · Cited by 49
“A large body of evidence has so far suggested that the consumption of pure oats is safe in the vast majority of patients with celiac disease.(6-25) Nonetheless, some concerns persist regarding the tolerance and the safety of oats for all patients with celiac disease.”
BackgroundResult
Metadata
- Authors
- Kilmartin, C., Lynch, S., Abuzakouk, M., Wieser, H., & Feighery, C.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-01
- Volume
- 52
- Issue
- 1
- Pages
- 47-52
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2136852554
- Cited by
- 86
- References
- 0
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. https://app.cochat.ai/papers/10.1136/gut.52.1.47
- The paper
- Kilmartin, C., Lynch, S., Abuzakouk, M., Wieser, H., & Feighery, C. (2003). Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut. https://doi.org/10.1136/gut.52.1.47
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.